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Abstract
Background: Optimal fluid therapy in the perioperative and critical care settings depends on understanding the
underlying cardiovascular physiology and individualizing assessment of the dynamic patient state.
Methods: The Perioperative Quality Initiative (POQI-5) consensus conference brought together an international
team of multidisciplinary experts to survey and evaluate the literature on the physiology of volume responsiveness
and perioperative fluid management. The group used a modified Delphi method to develop consensus statements
applicable to the physiologically based management of intravenous fluid therapy in the perioperative setting.
Discussion: We discussed the clinical and physiological evidence underlying fluid responsiveness and venous
capacitance as relevant factors in fluid management and developed consensus statements with clinical implications
for a broad group of clinicians involved in intravenous fluid therapy. Two key concepts emerged as follows: (1) The
ultimate goal of fluid therapy and hemodynamic management is to support the conditions that enable normal
cellular metabolic function in order to produce optimal patient outcomes, and (2) optimal fluid and hemodynamic
management is dependent on an understanding of the relationship between pressure, volume, and flow in a
dynamic system which is distensible with variable elastance and capacitance properties.
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Consensus statements
Physiological principles of fluid resuscitation
1. The ultimate goal of fluid and hemodynamic
management is to support normal cellular
metabolic function.
2. Achieving normal cellular metabolic function
requires maintenance or restoration of effective
coordinated function of the macrocirculation and
the microcirculation, as well as intact cellular
metabolism.
3. Practically speaking, most clinical management is
currently targeted at macrocirculatory variables and
surrogates of cellular metabolism (e.g., lactate, base
excess).
4. The therapeutic rationale of intravenous fluid
administration is to optimize macrocirculatory
function in order to improve or optimize
microcirculatory and cellular function.
5. There is a minimal intravascular volume required to
maintain cardiac output and stroke volume and
normal tissue perfusion. Below this volume, cardiac
output and blood pressure may be maintained at
the expense of microcirculatory blood flow and
cellular function.
6. The majority of intravascular volume is in the
venous circulation; therefore, the venous
capacitance is a critical determinant of effective
macrocirculatory function.
Physiology of fluid responsiveness
1. There is no readily available method of measuring
intravascular volume and it is uncertain if knowing
this static value would have clinical utility.
2. Optimal intravascular volume can only be
characterized through dynamic evaluation.
3. Administration of a fluid bolus as part of a fluid
challenge is a means of increasing intravascular
volume to evaluate the effect on stroke volume.
4. Fluid responsiveness is defined as a state of
recruitable stroke volume in response to
intravascular fluid administration.
Venous capacitance
1. The venous circulation is comprised of stressed and
unstressed volumes.
2. Stressed volume is the (theoretically measurable)
volume of blood that exerts distending pressure
against the venous wall. In contrast, unstressed
volume is the volume of blood up to the point of
filling the veins but without exerting any pressure
on the vessel walls.
3. Stressed volume determines the mean systemic
filling pressure (MSFP, the pressure of venous
return when cardiac activity is absent), related to
the elastic recoil of the venous system. The
difference between the MSFP and right atrial
pressure is the major factor determining venous
return to the heart. The MSFP provides driving
pressure against right atrial pressure which creates
a gradient promoting forward flow.
Practical implications
1. Full characterization of fluid responsiveness
requires consideration of the type, amount and
timing of fluid as well as the expected change in
stroke volume.
2. The best method of measuring fluid responsiveness
is a continuous or rapidly repeatable measure of
stroke volume.
3. A common approach to test fluid responsiveness is
the administration of 250-500 mL bulos in < 15 min
with a positive response defined by a 10-15%
increase in stroke volume.
4. The passive leg-raise maneuver replicates a
transient fluid bolus and predicts fluid
responsiveness without administration of
intravenous (IV) fluids (positive response definted
as > 10% increase in stroke volume), thereby
mitigating the risks of excess IV fluid
administration. This maneuver has limited utility in
the intraoperative setting.
5. Alternative methods for predicting fluid
responsiveness include stroke volume variation
(SVV), pulse pressure variation (PPV), systolic
pressure variation (SPV), and (in certain
mechanically ventilated patients) end-expiratory
occlusion test and respiratory systolic variation test.
All have limitations (Table 1).
6. Sonographic evaluation of IVC size, distensibility, or
collapsibility has limited and unproven utility at the
present time.
7. The actions of vasoactive drugs are typically
considered in relation to the arterial circulation but
many have significant effects on the venous
circulation.
8. Venoconstrictors (e.g., alpha agonists) increase
venous tone and thereby reduce venous
capacitance, thus increasing the stressed volume at
the expense of the unstressed volume. In a
hypovolemic patient, this reduction in unstressed
volume may in turn reduce microcirculatory blood
flow and thereby compromise cellular metabolism,
due to reduced perfusion despite maintenance of
normal blood pressure.
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9. Venodilators (e.g., nitroglycerin) reduce venous
tone and thereby increase venous capacitance and
decrease the stressed volume. This typically
decreases venous return and left ventricular end-
diastolic volume.
10. Intra-abdominal hypertension (e.g.,
pneumoperitoneum) may reduce venous return or
venous capacitance.
Background
More than 230 million major surgical procedures are
undertaken worldwide each year (Weiser et al., 2008).
Data from the USA and Europe suggests that approxi-
mately 18% of patients undergoing surgery will develop
a major postoperative complication and 3 to 5% will die
before hospital discharge (Weiser et al., 2008; Khuri
et al., 2005; Ghaferi et al., 2009; Pearse et al., 2012).
Those patients who develop a postoperative complica-
tion and survive to hospital discharge have diminished
functional independence and reduced long-term survival
up to 8 years after major surgery (Khuri et al., 2005). In-
terventions that reduce the risks of postoperative death
and complications, particularly in high risk patients have
become a priority in perioperative medicine (Jacobs,
2009). Perioperative goal-directed therapy (GDT), based
on the titration of fluids and vasoactive drugs to achieve
physiological, flow-related end points, is a promising ap-
proach to reduce postoperative complications and deaths
(Bednarczyk et al., 2017; Pearse et al., 2014; Hamilton
et al., 2011).
Optimal fluid therapy in the perioperative and critical
care settings depends on understanding the underlying
cardiovascular physiology and individualizing assessment
of the dynamic patient (Malbrain et al., 2018). Historical
approaches to fluid administration based on clinical
examination (e.g., “volume status”) or static measures of
cardiovascular function (e.g., central venous pressure or
pulmonary artery occlusion pressure) do not adequately
determine fluid needs or to predict response to fluid
administration (Van der Mullen et al., 2018). Dynamic
indices, such as SVV, utilize the concepts of the Frank-
Starling relationship that implicitly incorporate venous
capacitance and mean systemic filling pressure to predict
fluid responsiveness with good accuracy. However, in
the context of optimal fluid administration, knowledge
gaps remain for several key physiologic concepts and
clinical scenarios. This manuscript from the 5th Periopera-
tive Quality Initiative (POQI) group addresses fundamental
concepts in fluid responsiveness and venous capacitance in
order to provide an educational update and clinical guid-
ance related to perioperative fluid management.
Methods
POQI is an international, multidisciplinary non-profit
organization that organizes consensus conferences on
clinical topics related to perioperative medicine (Miller
et al., 2016). Each conference assembles a collaborative
group of diverse international experts from multiple
healthcare disciplines to develop consensus-based rec-
ommendations in perioperative medicine.
Applying a modified Delphi method, designed to use
the collective expertise of a diverse group of experts to
answer clinically important questions, we achieved con-
sensus on several topics related to fluid responsiveness
and fluid management.
Expert group
An international group of authorities, with specific con-
tent area expertise (based on the conduct of research
and education in this area), was invited to participate. In
total, 21 experts from around North America and
Europe met in Durham, NC, on June 16-17, 2018, to it-
eratively discuss the clinical and physiological evidence
of fluid responsiveness and venous capacitance as rele-
vant factors in fluid management, in order to develop
consensus statements with practical recommendations
Table 1 Summary of methods predicting fluid responsiveness
Method Threshold (%) Main limitations
Pulse pressure/stroke volume variations
(PPV/SVV) (Michard et al., 2000)
12 Cannot be used in case of spontaneous breathing, low tidal volume/lung compliance.
Need regular cardiac rhythm
Inferior vena cava diameter variations
(Vignon et al., 2017)
12 Cannot be used in case of spontaneous breathing, low tidal volume/lung compliance.
Need regular cardiac rhythm
Superior vena cava diameter variations
(Vignon et al., 2017)
36 Requires performing transesophageal Doppler. Cannot be used in case of spontaneous
breathing, low tidal volume/lung compliance. Need regular cardiac rhythm
Passive leg raising (Monnet et al., 2006) 10 Requires a direct measurement of cardiac output. May be inaccurate in intra-abdominal
hypertension
End-expiratory occlusion test
(Monnet et al., 2009)
5 Cannot be used in non-intubated patients. Cannot be used in patients who interrupt a
15-second respiratory hold
“Mini” fluid challenge (Muller et al., 2011) 6 Requires a precise technique for measuring cardiac output
“Conventional” fluid challenge (500mL)
(Vincent & Weil, 2006)
15 Requires a direct measurement of cardiac output.
Can induce fluid overload if repeated
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for a broad group of clinicians involved in intravenous
fluid therapy.
Process
Based on literature searches performed by POQI group
members, a list of relevant questions was collectively for-
mulated and circulated electronically prior to the meeting.
In the first plenary session, these questions were presented
to receive feedback and assistance in refining the questions.
There were then at least two Delphi rounds to develop the
statements before final agreement. This manuscript is based
on these multiple rounds of feedback from all the experts
present at the POQI meeting.
Results/discussion
Key physiologic and clinical terminology are shown in
Tables 2 and 3. Based on the literature identified by the
participants and discussions held both prior to the confer-
ence and during the iterative consensus-building process,
the following key concepts and core questions were consid-
ered most relevant to perioperative fluid management with
respect to fluid responsiveness and venous capacitance:
Key concepts
I. The ultimate goal of fluid therapy and
hemodynamic management is to provide the
conditions that enable normal homeostasis and
cellular metabolic function in order to produce
optimal patient outcomes.
II. Fluid and hemodynamic management is dependent
on the relationship between pressure, volume, and
flow in a dynamic system which is distensible with
variable elastance and capacitance properties.
Core questions
What are the physiologic and clinical goals of therapeutic
fluid (hemodynamic) resuscitation?
The ultimate goal of fluid therapy and hemodynamic
management is to provide the conditions that enable
normal cellular metabolic function in order to produce
optimal patient outcomes. The discrete goals of fluid
therapy exist at several levels: at the level of the macro-
circulation, the microcirculation, and at the cellular level
(Fig. 1). It is a limitation of medical science that cellular
metabolic function cannot be discretely and specifically
measured in the clinical context, particularly locally for
each of the wide variety of organ systems, and in con-
tinuous or repeatable series that permit clinical decision-
making. Because of this limitation, for clinical care, we
target intermediate variables of varying sensitivity, such as
cardiac output (CO), stroke volume (SV), mean arterial
pressure (MAP), central venous pressure (CVP), mixed
venous saturation (SvO2) and central venous oxygen satur-
ation (ScvO2), heart rate (HR), and urine output. While
these parameters may indicate the presence of, or the risk
for, cellular metabolic dysfunction, they are insensitive in
this regard and do not differentiate cellular dysfunction due
to macrocirculatory versus microcirculatory abnormalities.
Although restoration of the macrocirculation provides
the basis for normal microcirculatory and cellular meta-
bolic function, it does not guarantee them. Microcircula-
tory and cellular metabolic dysfunction may develop or
persist despite establishing normal microcirculatory
parameters, such as MAP and CO. However, because
dysfunction of the macrocirculation (e.g., hypotension)
often produces dysfunction at the microcirculatory and
cellular levels, the first step in therapeutic fluid resusci-
tation is restoration of the macrocirculation. It is worth
noting that restoration of the macrocirculation is not
achieved by reaching the same target in every patient.
Macrocirculatory parameters such as MAP and CO
should be personalized both for the individual and for
the patients’ current condition.
Recently, several investigators introduced the term
“hemodynamic coherence” to describe the physiologic
state in which improved macrocirculatory function re-
sults in improvements in the microcirculation (Ince,
2015; Morelli & Passariello, 2016). In contrast, the term
“hemodynamic incoherence” describes a physiological
state in which resuscitation to adequate macrocircula-
tory parameters does not result in an improved micro-
circulation. This state appears to happen frequently in
patients with sepsis. Four subsets of hemodynamic inco-
herence are proposed. In the first, obstruction of some
small blood vessels results in heterogeneous perfusion of
Table 2 Physiologic terminology
Term Definition
Arterial elastance The ratio of left ventricular end-systolic pressure
and stroke volume
Intravascular
volume
The blood volume within the vascular system
(arteries, capillaries, veins)
Mean systemic
filling pressure
The pressure of venous return when cardiac activity
is absent
Preload Volume defined by the distending pressure it
generates. In the heart, preload is LV wall stress at
end of diastole (= EDV)
Stressed volume The (theoretically measurable) volume of blood that
exerts distending pressure against the vascular wall
Total body water The amount of sodium-free water in the whole body,
commonly divided into the extracellular fluid space
and the intracellular fluid space
Unstressed
volume
The volume of blood just to the point of filling the
blood vessels but without exerting any pressure on
the vessel walls
Vascular
capacitance
The change in volume divided by the change in
pressure (i.e., the inverse of elastance)
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Table 3 Clinical terminology
Term Definition
Fluid bolus The rapid administration of intravenous fluid with therapeutic intent, most often to rapidly replace intravascular
volume in patients who are presumed to be fluid responsive.
Fluid challenge The rapid administration of intravenous fluid with diagnostic intent, most often to determine whether a patient
with hemodynamic compromise will benefit from further fluid administration.
Fluid overload
(overhydration)
Increased total body fluid volume (intravascular, interstitial, and intracellular). Fluid overload may be defined by
at least 10% increase in total body fluid volume. Sometimes referred to as “overhydration” or “hyperhydration.”
Fluid overload is the opposite of dehydration.
Fluid underload
(dehydrataion)
Decreased total body fluid volume. The percentage of fluid loss is defined by dividing the cumulative fluid
balance in liters by the patient’s baseline body weight and multiplying by 100%. Dehydration is defined by a
minimum value of 5% fluid loss. Dehydration is considered mild (5-7.5%), moderate (7.5-10%), while loss of
over 10% is considered severe. Sometimes referred to as “fluid underload.” Dehydration is the opposite of
fluid overload.
Fluid responsiveness An increase in stroke volume in response to an increase in intravascular volume. Also referred to as “volume
responsiveness.”
Hypovolemia Reduced intravascular volume and marked by increases in stroke volume when intravenous fluid is given
(i.e., the state of being fluid responsive). Clinical “hypovolemia” may exist, for example, from loss of
intravascular volume (e.g., hemorrhage) or from reductions in intravascular volume due to increases in venous
capacitance. Sometimes referred to as “fluid underload.”
Hypervolemia Hypervolemia is above normal or increased intravascular volume. Hypervolemia is the opposite of hypovolemia.
Passive leg raise A diagnostic postural maneuver raising the lower extremities up to 45 degrees from the recumbent position, to
transiently increase venous return from the lower extremities in order to measure the hemodynamic effect and
thus determine if a patient is fluid responsive.
Fig. 1 The macrocirculation, microcirculation, and the cellular level relevant for fluid therapy. Figure reused with the permission of the
Perioperative Quality Initiative (POQI). For permission requests, contact info@poqi.org
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the microcirculation. In the second, hemodilution results
in perfusion of capillaries with blood that has a low oxy-
gen carrying capacity. In the third, increased arterial re-
sistance and increased venous pressures lead to capillary
stasis due to low arterial-venous pressure gradients (see
below). In the fourth, edema causes large distances be-
tween capillaries and target tissues across which oxygen
and other energy substrates must diffuse to reach their
targets. Notably, administration of IV fluid may lead to
hemodilution, increased venous pressures, and edema for-
mation, thus contributing to hemodynamic incoherence.
The first goal of therapeutic fluid and hemodynamic
resuscitation is targeted at macrocirculatory parameters
(usually MAP) because they are measurable and they
represent the most apparent clinical markers of organ or
tissue perfusion, particularly in combination with other
clinical and laboratory assessments. When the MAP falls
below an organ’s autoregulatory range, there is an al-
most linear decrease in organ blood flow (Ackland et al.,
2019). The fall in blood flow is likely to occur at a higher
MAP in patients with long-standing hypertension due to
a shift in the autoregulatory range. Furthermore, differ-
ent vascular beds will lose autoregulation at different
MAPs. For example, the mammalian kidney loses auto-
regulation at a MAP of about 70 mmHg, the brain be-
tween 60-70 mm Hg, while the coronary circulation
loses autoregulation at a MAP of about 50-55 mmHg
(Drummond, 1997; Drummond, 2019; Paulson et al.,
1990; Bellomo & Di Giantomasso, 2001; Meng, 2019).
Therefore, the first hemodynamic goal is to achieve a
MAP > 65-70 mmHg to preserve organ perfusion (Sess-
ler et al., 2019).
The second and third goals of fluid and hemodynamic
resuscitation are targeted at the microcirculation and the
cellular levels. As noted above, dysfunction at these
levels may develop or persist despite the appearance of
normal macrocirculatory parameters, and devices to
characterize the microcirculation and cellular function
are not routinely available for clinical use. The microcircu-
lation may be assessed directly using tools such as intravi-
tal microscopy or laser Doppler flowmetry, or indirectly
using tissue oximetry and near infrared spectroscopy
(Tafner et al., 2017). Clinical examination (e.g., examin-
ation of capillary refill time or assessing for skin mottling)
may also give important clues about the adequacy of
perfusion in the microcirculation (Hernandez et al., 2019).
Efforts to realize the potential for microcirculatory moni-
toring for point-of-care diagnosis in real-time at the bed-
side are currently underway (Naumann et al., 2016).
In the clinical setting, the only reason to give any pa-
tient a fluid bolus is to increase the SV. In the absence
of an increase in SV, giving a fluid challenge serves no
useful purpose and is likely to be harmful. An increase
in SV will only occur if two conditions are met: (1) that
the fluid bolus increases the stressed blood volume caus-
ing an increase in MSFP, thereby increasing venous re-
turn, and (2) that both ventricles are functioning on the
ascending limb of the Frank-Starling curve.
Organ blood flow is driven by the difference in the
pressure between the arterial and venous circulation. For
example, the MAP minus the CVP is the driving force
for organ blood flow while the difference between post-
arteriolar and venular pressure determines microcircula-
tory flow. In circumstances of increased venous pressure,
such as high right atrial pressure, the backwards trans-
mission of pressure may impede microcirculatory flow
in the tissues and organs.
What is the role of venous capacitance in fluid and
hemodynamic therapy?
Fluid optimization must consider each of the fluid com-
partments in the body: total body water divided into the
intracellular and extracellular spaces, and more discretely
the plasma volume and blood volume, the interstitial fluid
volume, and the tissue-bound water volume (Fig. 2).
The left ventricle can only pump into the arterial circula-
tion; the volume of blood that it receives from venous return
(Funk et al., 2013). Because approximately two-thirds of the
total blood volume is in the venous system, the roles of the
venous system in general and venous capacitance specifically
are important for fluid therapy and hemodynamic manage-
ment. Through their capacitance function, veins and venules
regulate both regional and central blood volume and there-
fore cardiac preload: changes in venous tone directly influ-
ence SV and CO via the Frank-Starling mechanism. It is
important for anesthesia providers to understanding venous
return, venous capacitance, and their role in determining
CO.
With two-thirds of the blood volume within the
venous system, changes in venous blood volume play
a major role in determining venous return and CO
(Fig. 3). The venous system can be divided into two
theoretical compartments, the unstressed and the
stressed volume (Gelman, 2008). The intravascular
volume that fills the venous system to the point just
before intravascular pressure starts to rise is called
unstressed volume, whereas the volume that stretches
the veins and causes intravascular pressure to rise is
called the stressed volume (Figs. 4, 5). Another way to
think of stressed volume is the (theoretically measur-
able) portion of blood that exerts distending pressure
against the vein wall. Differentiating between these
two volumes is important because stressed volume
determines the MSFP, which is the pressure of venous
return when cardiac activity is absent, representing
the elastic recoil of the venous system. Through
MSFP, the stressed blood volume is a major contribu-
tor of venous pressure and therefore venous return.
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Fig. 3 Pressure and volume in the venous system. Figure reused with the permission of the Perioperative Quality Initiative (POQI). For permission
requests, contact info@poqi.org.
Fig. 2 Fluid compartments in adult humans. Figure reused with the permission of the Perioperative Quality Initiative (POQI). For permission
requests, contact info@poqi.org
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The unstressed volume normally accounts for about
75% of the venous blood volume, thus the venous system
acts as a reservoir that can rapidly recruit blood from
the unstressed blood volume to maintain venous return
to the right heart (Gelman, 2008; Peters et al., 2001).
Splanchnic and cutaneous veins are highly compliant and
represent the largest blood volume reservoirs. Alterations
in venous tone can change the relative proportions of the
unstressed and stressed volumes. For example, alpha ad-
renergic receptor agonists may increase venous tone and
thus increase the stressed volume (and simultaneously
lower the unstressed volume), increasing venous return to
the heart, raising SV and CO. (Kalmar et al., 2018;
Hamzaoui et al., 2010)
What is fluid responsiveness? How do we define it, is there
variation in proposed definitions, and is there variation
from those in clinical practice?
Assessing fluid responsiveness is the safest and most ef-
fective method to guide fluid therapy. Conceptually, fluid
responsiveness is defined as a state of recruitable SV in
response to fluid administration (see Table 3).
Intravascular volume and other measures of volume
status have limited utility and must always be considered
in the context of fluid responsiveness. Intravascular vol-
ume is distinct from total body fluid volume and must
be interpreted in the context of the individual patient.
For example, patients with excess total body fluid vol-
ume may have normal or low intravascular volume and
favorably respond to intravenous fluid administration.
Common clinical terminology is shown in Table 3, and
core concepts regarding volume status and fluid respon-
siveness include the following:
 All hypovolemic patients are fluid responsive but
not all fluid responsive patients are hypovolemic.
 Euvolemic and hypervolemic patients may be fluid
responsive (i.e., have preload recruitable SV).
Therefore, fluid non-responsiveness does not
indicate hypervolemia.
 The term fluid overload is confusing and is not the
appropriate term to indicate intravascular
hypervolemia (Vincent & Pinsky, 2018).
Clinically, fluid responsiveness is defined as an in-
crease in SV in response to an increase in intravascular
volume. Fluid responsiveness is one component of pre-
load responsiveness, which indicates a state of recruit-
able SV and is defined as a state in which increases in
end-diastolic volume (EDV) produce an increase in SV
(Pinsky, 2015). At the bedside, there are varying defini-
tions of fluid responsiveness based upon the setting and
the monitoring available for the patient, with the most
common definition being an increase of SV of 15% after
the patient receives 500 mL of crystalloid administered
over 10-15 min (Marik et al., 2009; Marik & Cavallazzi,
2013). Full characterization of fluid responsiveness re-
quires consideration of the type, amount and timing of
fluid, and the expected change in SV. It is noteworthy
that even among hemodynamically unstable patients,
only approximately half of patients are fluid responsive,
which means that fluid loading in the approximately
50% of non-responsive patients will likely cause more
harm than benefit.
The only method of directly measuring fluid respon-
siveness is continuous or rapidly repeatable measures of
SV in response to a fluid challenge, a passive leg raise
(PLR) maneuver, or controlled changes in intra-thoracic
pressure. Passive leg raising is a postural maneuver rais-
ing the lower extremities up to 45 degrees from the re-
cumbent position, which results in a transient increase
in the venous return from the lower extremities in order
to measure the hemodynamic effect and thus determine
if a patient is responsive to fluid therapy (Fig. 6). Because
PLR replicates a transient fluid bolus and predicts fluid
responsiveness without administration of IV fluids, it
Fig. 4 Depiction that differentiates stressed and unstressed volumes in the venous circulation. Figure reused with the permission of the
Perioperative Quality Initiative (POQI). For permission requests, contact info@poqi.org
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mitigates the risk of excessive IV fluids that may be par-
ticularly deleterious in patients at greater risk for or poor
tolerance of hypervolemia (e.g., heart failure, chronic kid-
ney disease, chronic lung disease). Alternative methods for
predicting fluid responsiveness include SVV, PPV, SPV,
and (in certain mechanically ventilated patients) the end-
expiratory occlusion test and respiratory systolic variation
test (see Table 1).
A common approach to test fluid responsiveness is the
administration of a 500 mL fluid challenge over < 15 min
with a positive response defined by a ≥ 15% increase in
SV, or a 250 mL fluid challenge over < 15 min with a
positive response defined by a ≥ 10% increase in SV.
However:
 Investigations into fluid responsiveness vary in fluid
type, volume, infusion time, and consequent change
in SV.
 Patients at risk for adverse effects from fluid
administration, such as CHF and ESRD, may receive
lower volume fluid challenges (e.g., 100 mL),
although the accuracy of the test to predict fluid
responsiveness is reduced (i.e., greater risk of false
negative test).
 The volume of fluid challenge depends on the type
of fluid given: crystalloid, colloid, or blood.
Recognizing that SV cannot be measured in all set-
tings, MAP or HR may be used as crude surrogate indi-
cators, recognizing they have limited predictive value.
Although the existing literature has examined the effect
of a fluid challenge on SV, a fluid challenge or PLR
could be useful in detecting whether inadequate preload
is contributing to hypotension. If the fluid challenge/
Fig. 5 Effects of fluid and vasoactive agents on cardiovascular
performance and the venous system. Figure reused with the
permission of the Perioperative Quality Initiative (POQI). For
permission requests, contact info@poqi.org. I Effect of volume
loading on mean systemic filling pressure (Pmsf) and (un)stressed
volume. Administration of a fluid bolus increases Pmsf (from Pmsf1
to Pmsf2, indicated respectively by position A (red dot) to B (green
dot) on the pressure/volume curve). Unstressed volume remains
constant while stressed volume increases. Total volume = unstressed
+ stressed increases, carrying a risk for fluid overload. See text for
explanation. II Effect of venoconstriction and venodilation on mean
systemic filling pressure (Pmsf) and (un)stressed volume.
Venoconstriction increases Pmsf (from Pmsf1 to Pmsf2, indicated
respectively by position A (red dot) to B (green dot) on the
pressure/volume curve). Unstressed volume decreases while stressed
volume increases. Total volume = unstressed + stressed remains
constant, resulting in an auto-transfusion effect. Venodilation as seen
in sepsis (vasoplegia) decreases Pmsf (from Pmsf1 to Pmsf3,
indicated respectively by position A (red dot) to C (blue dot) on the
pressure/volume curve). Unstressed volume increases while stressed
volume decreases. Total volume = unstressed + stressed remains
constant, resulting in an intravascular underfilling effect
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PLR does not correct hypotension, additional monitoring
may be appropriate and further management should
focus on vascular tone and chronotropy/inotropy (McE-
voy et al., 2019).
Under what situations can fluid responsiveness be used
clinically to decide when to give, and when to stop giving
fluid?
In the perioperative period, when fluid losses may be
substantial, fluid responsiveness is generally an indica-
tion for fluid administration but should be interpreted in
the clinical context of the patient. In patients who are
predicted to be non-responsive to fluid administration,
fluids should not be given unless other clinical indicators
suggest net benefit (e.g., need for water). The same as-
sessments apply to the decision to stop giving intraven-
ous fluids, which may be based upon the parameters
judging fluid responsiveness and the clinical context of
the patient for a global assessment or benefit and risk.
A key clinical question to ask when assessing a pa-
tient’s fluid responsiveness is whether increasing the SV
and CO is beneficial. For example, a patient might have
an adequate or high SV index and cardiac index and still
show evidence of fluid responsiveness. Giving fluid
might not be indicated since achieving a still higher SV
index and cardiac index might not yield important clin-
ical benefits.
All tests for fluid responsiveness have limitations
(Table 1). For example, SVV testing requires a regular
cardiac rhythm, the lack of patient inspiratory efforts,
and consistent changes in intrathoracic pressure pro-
duced by mechanical ventilation with tidal volumes of at
least 8 mL/kg predicted body weight. PLR testing requires
measurement of SV or CO and may produce false nega-
tive results in the setting of intra-abdominal hypertension.
While ultrasonographic evaluation of vena cava diam-
eter, distensibility, and collapsibility are increasingly
used in emergency medicine and critical care, its use
has numerous confounders (right heart dysfunction,
obstructive cardiac physiology, transpulmonary and
intraabdominal pressure, mode of ventilatory support)
and is not currently supported by evidence in the peri-
operative setting (Millington, 2019; Via et al., 2016). Fi-
nally, it is important to note that fluid bolus therapy
rapidly impacts the macrocirculation but does not ne-
cessarily alter the microcirculation or cellular function,
especially during the short time frame used to assess
fluid responsiveness. Further, the effects of crystalloid
boluses on SV and CO are often short-lived, as the
crystalloid fluid redistributes into the extravascular
extracellular space (Nunes et al., 2014; Aya et al., 2016).
Despite these limitations the assessment of fluid re-
sponsiveness probably leads to improved patient out-
comes among patients who undergo high-risk and
complex surgery (Bednarczyk et al., 2017).
What is the research agenda?
Our increasing understanding of the physiological and
clinical consequences of intravenous fluid therapy has
led to new and important questions that must be an-
swered in order to further refine our clinical use of
intravenous fluids. Future research should focus on the
following key areas:
 As the fundamental therapeutic goal of intravenous
fluid administration into the macrocirculation is to
optimize microcirculatory and cellular function, we
need better tools to assess both of those critical
features at the bedside.
Fig. 6 Stylized depiction of the passive leg raise (PLR) maneuver. Figure reused with the permission of the Perioperative Quality Initiative (POQI).
For permission requests, contact info@poqi.org
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 We need to identify or create methods with
everyday clinical utility to measure intravascular
volume, and for monitoring the benefits/harm of
fluid therapy.
 We need to better define exactly how to perform a
fluid challenge and a fluid responsisve patient.
 Emerging evidence suggests that fluid management
should always be individualized based on each
patients unique hemodynamics and cardiac funcion,
underlying disease process and co-morbidities. We
must recognize the dynamic nature of patient
trajectories throughout the perioperative period to
better define optimal fluid administration and
removal strategies.
Further research in these key areas will lay the founda-
tion for moving from group-targeted fluid therapy to
truly individualized fluid therapy.
Conclusions
In the POQI-5 consensus conference, we discussed the
clinical and physiological evidence of fluid responsiveness
and venous capacitance as relevant factors in fluid man-
agement and developed consensus statements with clinical
implications for a broad group of clinicians involved in
intravenous fluid therapy. Two key concepts emerged: (1)
The ultimate goal of fluid therapy and hemodynamic
management is to provide the conditions that enable nor-
mal cellular metabolic function in order to produce opti-
mal patient outcomes, and (2) fluid and hemodynamic
management is dependent on the relationship between
pressure, volume, and flow in a dynamic system which is
distensible and has variable elastance and capacitance.
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